JNJ — Johnson & Johnson Balance Sheet
0.000.00%
- $371.93bn
- $385.40bn
- $88.82bn
- 95
- 48
- 97
- 95
Annual balance sheet for Johnson & Johnson, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2021 January 3rd | 2022 January 2nd | 2023 December 31st | 2023 January 1st | 2024 December 29th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25,185 | 31,608 | 22,927 | 23,519 | 24,522 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 13,576 | 15,283 | 14,873 | 16,160 | 14,842 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 51,237 | 60,979 | 53,495 | 55,294 | 55,893 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 19,766 | 19,862 | 20,898 | 20,903 | 21,618 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 174,894 | 182,018 | 167,558 | 187,378 | 180,104 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 42,493 | 45,226 | 46,282 | 55,802 | 50,321 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 111,616 | 107,995 | 98,784 | 110,574 | 108,614 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 63,278 | 74,023 | 68,774 | 76,804 | 71,490 |
Total Liabilities & Shareholders' Equity | 174,894 | 182,018 | 167,558 | 187,378 | 180,104 |
Total Common Shares Outstanding |